Healthcare Services Industry Overview

Community Oncology Services Market Definition

The community oncology services market consists of sales of community oncology services by entities (organizations, and partnerships) of health practitioners who practice community oncology as a private physician-owned business not part of a hospital or academic or medical teaching institution. The community oncology services are chargeable or paid, it also includes insurances, and the prices paid in community oncology clinics are bit low as compared to hospitals. These community oncology clinics are basically near to home, based in a particular community area so people can easily access the services. The community oncology practice may be only a single oncologist, with one office and a support staff of physician extenders (a physician extender is a licensed health care provider (not a physician) that provides medical services performed by a physician such as physician assistants or nurse practitioners), nurses, pharmacists, or pharmacy technicians and other staff. Oncology is the study of cancer and an oncologist is a doctor who treats cancer and provides medical care for a person diagnosed with cancer. Cancer is a disease in which some of the body’s cells grow uncontrollably and spread to other parts of the body. The field of oncology based on treatments has three major areas: medical oncology, radiation oncology, and surgical oncology.

The enteric disease testing market consists of sales of enteric disease testing solutions by entities (organizations, sole traders, and partnerships) that are used for the diagnosis of enteric diseases such as food and water-borne diseases. Microorganisms such as viruses, bacteria, and parasites, cause enteric diseases that affect intestinal health. These pathogens can be contracted by contaminated food and drink, as well as by coming into contact with the excrement of an infected animal or person. Abdominal cramping, vomiting, nausea, and anorexia are common symptoms of enteric disorders, which can cause the body to lose fluids and nutrients. Enteric disease testing involves tests and technologies such as diagnostic assays and rapid tests, testing of stool specimens, complete blood count (CBC) test, blood culture test, urine test, antibody test, and bone marrow test for the diagnosis of the enteric disease-causing agent. The main disease types of enteric disease testing are bacterial enteric disease, parasitic enteric disease, viral enteric disease, and others. Bacteria are a type of disease-causing microorganism that can be found almost anywhere, including in soil and water. Salmonella, campylobacter, shigella, clostridium difficile, and diverse strains of E. coli are examples of enteric bacterial pathogens. The different technologies include traditional, rapid, convenience-based, polymerase chain reaction (PCR), immunoassay, chromatography, and spectrometry, others. The tests are used by hospitals, research centers, clinics, others. The enteric disease testing market research report is one of a series of new reports from The Business Research Company that provides enteric disease testing market statistics, including enteric disease testing industry global market size, regional shares, competitors with a enteric disease testing market share, detailed enteric disease testing market segments, market trends and opportunities, and any further data you may need to thrive in the enteric disease testing industry. This enteric disease testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global enteric disease testing market size is expected to grow from $3.87 billion in 2021 to $4.06 billion in 2022 at a compound annual growth rate (CAGR) of 4.9%. The global enteric disease market size is expected to grow to $4.70 billion in 2026 at a CAGR of 3.7%. The increasing cases of diarrhea and hemolytic urea syndrome (HUS) are expected to propel the growth of the enteric disease testing market going forward. The major cause for the rise in diarrhea disease cases is the consumption of contaminated food and water. The disorder hemolytic urea syndrome affects the blood and blood vessels and is most common in children who have had diarrhea illness. Diarrheal disease and HUS are one of the leading causes of death in children under the age of five. The increasing cases of diarrhea and hemolytic will need testing solutions which will raise the demand for enteric disease testing solutions. For instance, according to the Centers for Disease Control and Prevention, diarrhea is the second greatest cause of mortality among children under the age of 5, 801 thousand worldwide, accounting for one out of every nine child deaths every year. Thus, the increasing incidences of enteric diseases will drive the growth of the enteric disease testing market. The opening of new laboratories by companies for providing food-testing services is emerging as a key trend in the enteric disease testing market. Major companies operating in enteric disease testing market are focused on opening new laboratories to provide food testing services. For instance, in June 2021, SGS Group, a Switzerland-based company that provides verification, testing, inspection, and certification services announced the opening of NATA ISO17025 Accredited Laboratory, a latest addition to the SGS group which offers internationally recognized quality testing to the food manufacturing, retail market and hospitality segments. Furthermore, In June 2019, UK based firm i2 Analytical Group launched i2 FAST (Food Analysis & Safety Testing), a new food testing laboratory that is built on scientific principles and is headed by scientists. In this laboratory, pesticides, microbiological, contaminants, nutritional, allergy, and mycotoxin testing are all available for the food and associated sectors. In January 2019, Luminex Corporation, a US-based developer, manufacturer, and marketer of biological testing technologies acquired MilliporeSigma for $75 million. Through this acquisition, Luminex will expand its current portfolio of flow-based detection devices while also increasing direct relationships with cellular analysis researchers. MilliporeSigma is a Germany-based firm that provides enteric disease testing services. Major players in the enteric disease testing market are Becton Dickinson, Biomerica Inc., Biomerieux, Bio-Rad Laboratories Inc., Cepheid, Coris Bioconcept, DiaSorin Molecular LLC, Meridian Life Science, Quest Diagnostics, Trinity Biotech, Abbott Laboratories, GlaxoSmithKline, Sanofi, Bayer Pharma, and Thermo Fisher Scientific. North America was the largest region in the enteric disease testing market in 2021. Europe is expected to be the fastest-growing region in the global enteric disease testing market during the forecast period. The regions covered in the global enteric disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the global enteric disease testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global enteric disease testing market is segmented - 1) By Disease Type: Bacterial Enteric Disease, Parasitic Enteric Disease, Viral Enteric Disease, Others 2) By Technology: Traditional, Rapid, Convenience-Based, Polymerase Chain Reaction (PCR), Immunoassay, Chromatography and Spectrometry, Others 3) By Application: Hospitals, Research Centers, Clinics, Others

The oxygen flow meter market consists of sales of oxygen flowmeters by entities (organizations, sole traders, and partnerships) that are used to measure and regulate the amount of oxygen delivered to patients who are receiving oxygen therapy. It can not only accurately detect the flow of oxygen in real-time, but it can keep healthcare providers informed about a patient's oxygen absorption status. Oxygen flowmeters are now routinely utilized in hospitals at all levels. The main types of oxygen flow meters are double flange type, plug-in type, and others. Plug-in type O2 flow meters are mostly used in the healthcare industry, such as in hospitals, surgical facilities, and clinics, to monitor or control high-pressured oxygen provided from an O2 cylinder. The different calibration types include automatic, and manual and are used in healthcare, industrial, aerospace, chemical, and other applications. The oxygen flow meters market research report is one of a series of new reports from The Business Research Company that provides oxygen flow meters market statistics, including oxygen flow meters industry global market size, regional shares, competitors with a oxygen flow meters market share, detailed oxygen flow meters market segments, market trends and opportunities, and any further data you may need to thrive in the oxygen flow meters industry. This oxygen flow meters market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global oxygen flow meters market size is expected to grow from $1.39 billion in 2021 to $1.53 billion in 2022 at a compound annual growth rate (CAGR) of 9.7%. The global oxygen flow meter market size is expected to grow to $2.01 billion in 2026 at a CAGR of 7.1%. The increasing number of COVID-19 cases in the world is expected to propel the growth of the oxygen flowmeter market going forward. Coronavirus disease (COVID-19) is an infectious disease caused by the virus called SARS-CoV-2. The majority of those infected with the virus will experience mild to moderate respiratory symptoms and require external oxygen to breathe. For instance, according to the Worldometer, a US-based reference website that provides live world statistics, the total new COVID-19 cases found on 25th April 2022 is 510 million has jumped to 511 million on 27th April 2022. Therefore, the increasing number of COVID-19 cases drives the oxygen flowmeter market moving forward. New product developments have emerged as a key trend gaining popularity in the oxygen flowmeters market. Major companies operating in the oxygen flowmeters sector are focused on new product innovations to meet consumer demand and strengthen their position. For instance, In August 2021, Guangzhou Aosong Electronics Company Ltd, a China-based manufacturer of temperature and humidity sensors launched a new intelligent digital gas mass flow meter based on advanced semiconductor technology. This product features high sensitivity, a versatile output mode, and a wide range of stability. The AMS2106 uses thermal mass flow measurement without the need for additional temperature and pressure correction from the client, ensuring high-precision flowmeter calculations, high sensitivity, and the ability to quickly detect the minimum starting flow rate and begin the calculation. In January 2022, ICU medical Inc, a US-based medical company acquired Smiths Medical for an undisclosed amount. With this acquisition, ICU medical Inc will continue providing innovation, quality, and value to clinical customers worldwide. Smiths Medical is a US-based company that provides oxygen flow meters. Major players in the oxygen flow meters market are D.Z. Medicale S.r.l., Heyer Medical AG, Ohio Medical Corporation, Megasan Medical, Precision Medical Inc., HERSILL, Penlon Ltd, BURAK Metering Pvt Ltd, Amcaremed Technology Co. Limited, Dwyer Instruments Ltd., Burak Metering, Deluxe Industrial Gases, Sumukha Meditek, and Ashish Engineering. North America was the largest region in the oxygen flow meters market in 2021. The regions covered in the global oxygen flow meter market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the oxygen flow meters market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global oxygen flow meters market is segmented - 1) By Type: Double Flange Type, Plug-In Type, Others 2) By Calibration Type: Automatic, Manual 3) By Application: Healthcare, Industrial, Aerospace, Chemical, Others

The healthcare EDI market consists of sales of healthcare electronic data interchange systems by entities (organizations, sole traders, and partnerships) that are used to manage the patient's medical history, the medication data, and the emergency services record, which are considered critical data in the healthcare sector. Electronic Data Interchange (EDI) is the software medium for the transaction of data among various healthcare providers and payers via computer systems. The organizer can process and track claims through the entire billing cycle via the EDI service. The main types of transactions in healthcare EDI are claim management, healthcare supply chain, and others. Claim management is the organization, billing, filing, updating, and procedure of healthcare claims connected to patient diagnoses, medication, and treatment. The different components include software, hardware, and services, and include various modes of delivery such as mobile, VAN, web & cloud-based, and point-to-point. These are used by healthcare providers, payers, pharmacies, and other end-users. The healthcare EDI market research report is one of a series of new reports from The Business Research Company that provides healthcare EDI market statistics, including healthcare EDI industry global market size, regional shares, competitors with a healthcare EDI market share, detailed healthcare EDI market segments, market trends and opportunities, and any further data you may need to thrive in the healthcare EDI industry. This healthcare EDI market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global healthcare EDI market size is expected to grow from $3.64 billion in 2021 to $4.03 billion in 2022 at a compound annual growth rate (CAGR) of 10.7%. The global healthcare electronic data interchange market size is expected to grow to $5.70 billion in 2026 at a CAGR of 9.1%. The increasing government support for healthcare is expected to propel the growth of the healthcare EDI market growing forward. Healthcare EDI is used to share information between the departments and branches in super-specialty hospitals. Healthcare EDI software helps to transmit details including coordination of benefits, claims status and information, insurance data, payment data, and eligibility forms among healthcare. Rising government support for the healthcare industry helps the healthcare sector in developing new equipment and to provide better services for the people. It also helps to increase technology in government hospitals. For instance, according to the Indian Economic Survey, in 2021-22, India's public healthcare spending reached 2.1%, up from 1.8% in 2020-21. Furthermore, the Union budget for 2022 allocated 11.28 billion for the growth of health care. Therefore, the increasing government support for healthcare drives the demand for the healthcare EDI market. Technological advancements have emerged as the key trend gaining popularity in the healthcare EDI market. Major companies operating in the healthcare EDI market are focused on new technological innovations to sustain their position in the market. For instance, in 2020, Waystar, a US-based company that develops a technology platform which simplifies and unifies the healthcare payments cycle launched its new analytics software based on revenue cycle technology. It facilitates access to vital data insights and aids medical organizations during the pandemic situation. Waystar fast-tracked the launch of this new software, which offers the intelligence healthcare leaders require to make strategic, reliable, and correct decisions in this environment. In August 2020, Waystar, a US-based company that develops a cloud-based revenue cycle management platform and healthcare solutions acquired eSolutions for a deal amount of $1.3 billion. Through this acquisition, Waystar would combine both commercial and government payers into a single payment platform. This acquisition also helps Waystar to deliver outstanding innovation to the industry, helping healthcare organizations to accelerate income collection while reducing administrative costs and redundant tasks. eSolutions is a US-based healthcare technology company that develops revenue cycles. Major players in the healthcare EDI market are McKesson Corporation, Optum, Allscripts, GE Healthcare, Cognizant, Cerner, Dell Technologies Inc., The SSI Group, Tallan Inc., Quadax, AthenaHealth, Schreiner Group, MuleSoft LLC, and Boomi. North America was the largest region in the healthcare electronic data interchange market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global healthcare EDI system market during the forecast period. The regions covered in the global healthcare EDI market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the healthcare EDI market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global healthcare EDI market is segmented - 1) By Component: Software, Hardware, Services 2) By Transaction: Claim Management, Healthcare Supply Chain, Others 3) By Mode of Delivery: Mobile, VAN, Web and Cloud-Based, Point-to-Point 4) By End-User: Healthcare Provider, Payer, Pharmacies, Others

The nootropics market consists of sales of nootropic solutions and services by entities (organizations, sole traders, and partnerships) that help to boost brain performance. Nootropics refer to memory-enhancing substances which having a stimulation effect. The nootropics include caffeine, creatine, vitamins, and minerals, which are used to increase memory, strength, or other cognitive functions. They may have some effects on memory, thinking, or other mental functions but do not treat the diseases. The main types of drugs in nootropics are prescription nootropics and OTC nootropics. The prescription nootropics help to provide stimulant effects, counteracting the symptoms of medical conditions such as attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, or narcolepsy. The various forms include capsules or tablets, powder, drinks, and others, and are distributed through several channels such as online, and offline. The nootropics are used in memory enhancement, mood, and depression, attention and focus, longevity and anti-aging, sleep and recovery, and anxiety. The nootropics market research report is one of a series of new reports from The Business Research Company that provides nootropics market statistics, including nootropics industry global market size, regional shares, competitors with a nootropics market share, detailed nootropics market segments, market trends and opportunities, and any further data you may need to thrive in the nootropics industry. This nootropics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global nootropics market size is expected to grow from $3.36 billion in 2021 to $3.95 billion in 2022 at a compound annual growth rate (CAGR) of 17.5%. The global nootropic market size is expected to grow to $6.61 billion in 2026 at a CAGR of 13.7%. The increasing expenditure on health and wellness is expected to propel the growth of the nootropics market going forward. Health and wellness are generally defined as a method that an individual respects to reach mental health and physical wellbeing. Mental and physical health involves diving deep into the health and wellness industry. Nootropics are useful in maintaining an individual's health and wellness, as a result, if the demand for healthcare and wellness is increasing, so will the need for nootropics. For instance, according to Global Wellness Institute, a US-based non-profit organization, the global mental wellness market was valued at $122 billion in 2019 and grew by 7.2%, reaching $131 billion in 2020. Therefore, the increasing expenditure on healthcare and wellness drives the nootropics market. The adoption of vegan nootropics is gaining popularity in the global nootropics market. Major companies operating in the nootropics market are going to new organic product innovations to meet consumer demand and sustain their position in the market. For instance, in April 2019, Gaia Herbs, a US-based company that manufactures pharmaceuticals and nootropics launched a new line of 3 new vegan nootropics supplements known as bacopa, agile mind, and nootropic which are focused, to support mental performance. This product is a combination of science and tradition that create proprietary blends. In April 2021, Unilever Global, a UK-based company that manufactures nootropics acquired Onnit for an undisclosed amount. Through this acquisition, Onnit entirely sets Unilever in an increasing portfolio of advanced wellness and supplement brands that include olly, equilibria, liquid I.V., and SmartyPants Vitamins. Onnit is a US-based company operating in nootropics and a specialist in functional nutrition, fitness, mental, and emotional wellness needs. Major players in the nootropics market are Accelerated Intelligence Inc., AlternaScript, HVMN, Mental Mojo LLC, Peak Nootropics, PureLife Bioscience Co. Ltd., Blue Brain Boost, NooCube, Mind Lab Pro, TruBrain, Neu Drinks, Superior Supplement Manufacturing, Equinox Nutraceuticals, and Natural Stacks. North America was the largest region in the nootropics market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global nootropics market during the forecast period. The regions covered in the global nootropics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the nootropics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global nootropics market is segmented - 1) By Drug Type: Prescription Nootropics, OTC Nootropics 2) By Form: Capsules or Tablets, Powder, Drinks, Others 3) By Distribution Channel: Offline, Online 4) By Application: Memory Enhancement, Mood and Depression, Attention and Focus, Longevity and Anti-Aging, Sleep and Recovery, Anxiety

The home healthcare market consists of sales of home healthcare services by entities (organizations, sole traders, and partnerships) that are used to help individuals to improve health function as it helps to provide initial treatment and avoid hospitalization. Home healthcare refers to a set of activities conducted to keep the home healthcare equipment in working condition. Home healthcare is supportive care provided by any professional caregiver in their respective homes where the patient is staying. It is a cost-effective way to deliver quality care at patients’ homes. The main types of equipment in home healthcare are therapeutic, diagnostic, and mobility care. Therapeutic equipment refers to a set of activities conducted to keep them in working condition. The therapeutic equipment includes home respiratory therapy, insulin delivery devices, IV pumps, and others. The different indications include cardiovascular disorders & hypertension, diabetes, respiratory diseases, pregnancy, cancer, wound care, and others and involve various services such as rehabilitation services, respiratory therapy services, infusion therapy services, and others. The home healthcare market research report is one of a series of new reports from The Business Research Company that provides home healthcare market statistics, including home healthcare industry global market size, regional shares, competitors with a home healthcare market share, detailed home healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the home healthcare industry. This home healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global home healthcare market size is expected to grow from $277.97 billion in 2021 to $306.78 billion in 2022 at a compound annual growth rate (CAGR) of 10.4%. The global home healthcare market size is expected to reach $427.95 billion in 2026 at a CAGR of 8.7%. The rapid increase in the aging population is significantly driving the growth of the home healthcare market going forward. The increase in the aging population will boost the demand for healthcare as the aged people are more prone to chronic diseases, which is a favorable factor to the home healthcare market, and increases the overall reach of various home health services. This will reduce the unnecessary visits time involved in traveling, hospital admission, and others. For instance, in 2019, according to the United Nations Organisations, a US-based intergovernmental organization, 1 out of 11 people in the United States were above the age of 65, which will increase to 1 out of 6 people by 2050. Therefore, the increase in the aging population is driving the growth of the home healthcare market. Technological advancements have emerged as a key trend gaining popularity in the home healthcare market. Companies operating in the home healthcare market are adopting new technologies to reinforce their position in the market. For instance, in August 2019, Zorgers, an India-based home healthcare company launched an Android app that aims to help monitor its patients remotely. When needed, the app also gives information on the patients' health and navigation to caretakers. It makes healthcare professionals' lives easier and keeps them connected to the healthcare ecosystem all day. Caregivers can also benefit from the app by using it to keep track of their clients' locations, addresses, and contact information. As a result, when a new Carer joins the team, the app assists him or her in tracking the patient's particular facts while also keeping the contact information secure. In November 2021, Addus Homecare, a US-based company that provides home healthcare services acquired Armada hospice for a deal amount of $29 million. This acquisition helps Addus Homecare in creating multiple markets in various levels of home care services. Armada Hospice is a US-based company that provides hospital and health care services. Major players in the home healthcare market are Fresenius SE & Co KGaA, F. Hoffmann-La Roche AG, Resmed Inc., American Well, Apple Inc., CVS Health, Humana Inc., LHC Group Inc., Kindred Healthcare, Honor Home Care, Zorgers, Grand World Elder Care, and MediCar. North America was the largest region in the home healthcare market in 2021. Asia-Pacific is expected to be the fastest-growing region in the global home healthcare market during the forecast period. The regions covered in the global home healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the home healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global home healthcare market is segmented - 1) By Equipment: Therapeutic, Diagnostic, Mobility Care 2) By Service: Rehabilitation Services, Respiratory Therapy Services, Infusion Therapy Services, Others 3) By Indication: Cardiovascular Disorders and Hypertension, Diabetes, Respiratory Diseases, Pregnancy, Cancer, Wound Care, Others

The preventive healthcare technologies and services market consists of sales of preventive healthcare technologies and services by entities (organizations, sole traders, and partnerships) that are used to take measures and identify future illnesses and treatment by the healthcare providers. Preventive healthcare technologies include screenings, check-ups, and patient counselling to identify and prevent health problems. Preventive healthcare technology devices are more commonly used to measure daily lives health patterns like blood oxygen saturation, heart rate, blood pressure, and sleep patterns. The main types of preventive healthcare technologies and services market are early detection and screening technologies, vaccines, chronic disease management technologies, advanced technologies to reduce errors. Early detection and screening technologies are used to identify future health conditions of patients. The early detection and screening technologies include x-ray, CT, ultrasound, magnetic resonance imaging (MRI). The applications of preventive healthcare technologies and services are in hospitals and clinics. The preventive healthcare technologies and services market research report is one of a series of new reports from The Business Research Company that provides preventive healthcare technologies and services market statistics, including preventive healthcare technologies and services industry global market size, regional shares, competitors with a preventive healthcare technologies and services market share, detailed preventive healthcare technologies and services market segments, market trends and opportunities, and any further data you may need to thrive in the preventive healthcare technologies and services industry. This preventive healthcare technologies and services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global preventive healthcare technologies and services market size is expected to grow from $192.59 billion in 2021 to $219.76 billion in 2022 at a compound annual growth rate (CAGR) of 14.1%. The global preventive healthcare market size is expected to grow to $381.92 billion in 2026 at a CAGR of 14.8%. An increase in the older population pool is increasing demand for the preventive healthcare technologies and services market. Medical problems are known to increase with age, due to this preventing or identifying problems at an early stage can decrease the risk and intensity of the issue. According to the United Nations survey, an intergovernmental organization, there were around 703 million persons aged 65 years or over in the world in 2019, and it is projected to reach around 1.5 billion in 2050. This increase in the aged people population can also directly impact the preventive healthcare technologies market. The use of artificial intelligence (AI) as a preventive healthcare technique is a rising trend in the preventive healthcare technologies and services market. Many medical conditions such as identifying type 1 diabetes, indications of Alzheimer's, and predicting breast cancer, cardiovascular diseases can be identified using the advanced AI technologies. Some orthopedic spine surgery experts from Boston-based Massachusetts General Hospital suggest that machine learning and AI can also predict personalized and accurate assumptions of where fractures will happen on a patient based on the history of the patient and the historic database available. Similarly, in November 2020, Medtronic, American-Irish registered medical device company acquired France based company, Medicrea that provides AI-driven surgical planning and predictive modelling tools which helps to improve the quality of spine management. In November 2021, Hellman & Friedman and Bain Capital, a private equity firm, acquired Athenahealth, Inc for $17 billion. This acquisition will help Athenahealth become the largest and most innovative provider of cloud-based electronic medical records and physician practice solutions in the USA. Athenahealth, Inc is a cloud computing vendor that enhances the clinical quality, operational efficiency, and delivery of preventive care to many patients in the US. Major players in the preventive healthcare technologies and services market is Omnicell Inc., Merck & Co. Inc., McKesson Corporation, GlaxoSmithKline plc., Medtronic, Quest Diagnostics Inc., Alere, Myriad Genetics Inc., Omron Healthcare, Pfizer Inc., Sanofi, Healthway, Inc, Tivity Health, Dilon Technologies Inc., Novx Systems, Scripto LLC, Viatronix Inc., U-Systems Inc. North America was the largest region in the preventive healthcare technologies and services market in 2021. Europe is expected to be the fastest-growing region in the global preventive healthcare services and technologies market during the forecast period. The regions covered in the preventive healthcare technologies and services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the global preventive healthcare technologies and services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global preventive healthcare technologies and services market is segmented - 1) By Type: Early Detection and Screening Technologies, Vaccines, Chronic Disease Management Technologies, Advanced Technologies to Reduce Errors 2) By Application: Hospitals, Clinics

The blood gas and electrolyte analyzers market consists of sales of the blood gas and electrolyte analyzers products by entities (organizations, sole traders, and partnerships) that are used to measure combinations of pH, blood gas, electrolytes, and metabolites parameters from whole blood samples. Electrolytes are measured in the clinical laboratories in both serum and whole blood samples received for arterial blood gas (ABG) analysis. The main blood gas and electrolyte analyzer products are blood gas analyzers, electrolyte analyzers, combined analyzers, and consumables. Blood gas analyzers are utilized to measure blood gas, pH, electrolytes, and some metabolites in entire blood specimens. They can calculate pH, carbon dioxide and oxygen partial pressures, and the concentrations of a variety of ions and metabolites. Blood gas and electrolyte analyzers are of various modalities such as portable, laboratory, and benchtop. Blood gas and electrolyte analyzers are used by end-use such as central laboratories, point-of-care, diagnostic centers, hospitals, and other end-users. The blood gas and electrolyte analyzers market research report is one of a series of new reports from The Business Research Company that provides blood gas and electrolyte analyzers market statistics, including blood gas and electrolyte analyzers industry global market size, regional shares, competitors with a blood gas and electrolyte analyzers market share, detailed blood gas and electrolyte analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the blood gas and electrolyte analyzers industry. This blood gas and electrolyte analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global blood gas and electrolyte analyzers market size is expected to grow from $2.84 billion in 2021 to $2.98 billion in 2022 at a compound annual growth rate (CAGR) of 5.0%. The global blood gas and electrolyte analyzer market size is expected to grow to $3.75 billion in 2026 at a CAGR of 5.9%. The increase in the number of patients led to more blood sample testing, contributing to the growth of the blood gas and electrolyte analyzers market. Blood tests are used for a variety of purposes, including determining cholesterol and blood glucose levels. These can help keep track of the risk of heart disease, vascular disease, and diabetes, as well as how well the problem is treated. For instance, in 2021, of the 118.5 million blood donations received worldwide, 40% are collected in high-income countries, which account for 16% of the global population. Children under the age of five years old receive up to 54% of blood transfusions in low-income nations, but in high-income countries, the most frequently transfused patient group is over 60 years old, accounting for up to 75% of all transfusions. Thus, the increase in the number of patients led to more blood sample testing is contributing to the growth of the blood gas and electrolyte analyzers market. Increasing technological advancements are a key trend gaining popularity in the blood gas and electrolyte analyzers market. Blood gas analysis is typically used in hospital point of care (POC) settings, where easily and accurate results are required. This involves emergency rooms, intensive care units, and operating rooms. For instance, in 2020, Swiss multinational healthcare company, Roche introduced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that provides clinicians to achieve results for arterial blood gas values from patients with respiratory or metabolic abnormalities through the same, less invasive venous puncture by the utilized of a digital algorithm. The analysis allows clinicians with information about a patient’s pulmonary function and acid-base status, both of which are required to make a diagnosis, allow treatment, and monitor progress. In May 2020, Roche Holding, the Switzerland-based research healthcare company engaged in the discovery, development, and commercialization of pharmaceuticals and diagnostics, acquired Obi Medical for an undisclosed amount. This acquisition will help Roche to improve Roche v-TAC, a digital diagnostic solution that provides medical institutions to achieve results for arterial blood gas values in the same manner. The Roche v-TAC has been improved by integrating Roche’s Cobas infinity point of care solutions & Obi’s v-TAC technology. Obi Medical is a Denmark-based company engaged in manufacturing v-Tac software for blood gas testing that manufacturers blood gas and electrolyte analyzers. Major players in the blood gas and electrolyte analyzers market are OPTI Medical Systems Inc., EDAN Instruments Inc., The Samsung Group, Radiometer Medical ApS, Novastat, Erba Mannheim, Roche Holding AG, Medica Corp, Siemens AG, Abbott Laboratories, Roche Diagnostics, Instrumentation Laboratory, Alere Inc., Dalko Diagnostics, Erba. North America was the largest region in the blood gas and electrolyte analyzers market in 2021 and is also expected to be the fastest-growing region in the global blood gas and electrolyte analyzer market during the forecast period. The regions covered in the global blood gas and electrolyte analyzers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the global blood gas and electrolyte analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The global blood gas and electrolyte analyzers market is segmented - 1) By Product: Blood Gas Analyzers, Electrolyte Analyzers, Combined Analyzers, Consumables 2) By Modality: Portable, Laboratory, Benchtop 3) By End-Use: Central Laboratories, Point-of-Care, Diagnostic Centers, Hospitals, Others